| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Dr. Reddys Lab | Pharmaceuticals& Drugs | 1,293.3 |
-13.55 (-1.04%) |
Mid Cap | 32,644 | 66.7 | 16.93 | 19.4 | 2.9 | |
| Zydus Lifesciences | Pharmaceuticals& Drugs | 938.9 |
-1.2 (-0.13%) |
Mid Cap | 23,242 | 49.1 | 19.92 | 19.1 | 3.6 | |
| Lupin | Pharmaceuticals& Drugs | 2,377.9 |
-81.85 (-3.33%) |
Mid Cap | 22,708 | 116.6 | 14.55 | 20.4 | 4.8 | |
| Glenmark Pharma | Pharmaceuticals& Drugs | 2,364.4 |
-6.7 (-0.28%) |
Mid Cap | 13,322 | 37.7 | 9.67 | 62.6 | 6.7 | |
| Aurobindo Pharma | Pharmaceuticals& Drugs | 1,488.5 |
9.95 (0.67%) |
Mid Cap | 10,933 | 36.7 | 15.17 | 40.6 | 3.9 | |
| Mankind Pharma | Pharmaceuticals& Drugs | 2,427.2 |
51.75 (2.18%) |
Mid Cap | 9,498 | 41.3 | 18.61 | 58.8 | 6.3 | |
| Alkem Laboratories | Pharmaceuticals& Drugs | 5,576.8 |
-14.05 (-0.25%) |
Mid Cap | 8,813 | 183.5 | 23.18 | 30.4 | 4.7 | |
| Max Healthcare Inst | Hospital &HealthcareServices | 1,012.4 |
-2.75 (-0.27%) |
Mid Cap | 7,028 | 14.6 | 16.05 | 69.4 | 9.5 | |
| Ipca Laboratories | Pharmaceuticals& Drugs | 1,551.8 |
-6.15 (-0.39%) |
Mid Cap | 6,635 | 31.7 | 12.45 | 48.9 | 5.1 | |
| Abbott India | Pharmaceuticals& Drugs | 26,661.5 |
-30.7 (-0.12%) |
Mid Cap | 6,409 | 717.3 | 22.1 | 37.2 | 12.9 | |
| Laurus Labs | Pharmaceuticals& Drugs | 1,229.5 |
23 (1.91%) |
Mid Cap | 5,554 | 16.5 | 5.63 | 74.7 | 12.5 | |
| Narayana Hrudayalay | Hospital &HealthcareServices | 1,819.8 |
-42.35 (-2.27%) |
Mid Cap | 5,483 | 38.1 | 14.35 | 47.7 | 8.9 | |
| Lenskart Solutions | MedicalEquipment/Supplies/Accessories | 489.5 |
1.5 (0.31%) |
Mid Cap | 4,039 | 1.1 | 4.65 | 451.9 | 9.3 | |
| Glaxosmithkline Phar | Pharmaceuticals& Drugs | 2,484.7 |
5.75 (0.23%) |
Mid Cap | 3,749 | 60.3 | 23.42 | 41.2 | 21 | |
| Biocon | Pharmaceuticals& Drugs | 380.6 |
-2.05 (-0.54%) |
Mid Cap | 2,243 | 0.2 | 8.04 | 1,658.2 | 2.3 | |
| Anthem Biosciences | Pharmaceuticals& Drugs | 784.6 |
5.65 (0.73%) |
Mid Cap | 1,841 | 9 | 27.24 | 87.1 | 14.9 | |
| Fortis Healthcare | Hospital &HealthcareServices | 952.1 |
4.6 (0.49%) |
Mid Cap | 1,446 | 2.2 | 9.99 | 440.6 | 7.8 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: